FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to pulmonology. The method for treatment of patients with pulmonary tuberculosis includes anti-tuberculosis therapy. Additionally, preparations are administered according to the following scheme: polyvalent antigangrenous horse serum (AGS) 60,000 ME per 400 ml of saline for 3 hours, on the second day, octagam is administered intravenously at a dose of 5 ml/kg 1 time per day, enterofuril R is administered enterally at a dose of 5 ml for three days 3 times a day, ViferonR suppository 500,000 IU at night for three days.
EFFECT: invention provides effective treatment of patients with pulmonary tuberculosis.
1 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PULMONARY TUBERCULOSIS | 2013 |
|
RU2549485C2 |
METHOD OF TREATMENT OF NECROTIC ENTEROCOLITIS | 2017 |
|
RU2665947C1 |
METHOD FOR TREATING SEPSIS | 2004 |
|
RU2271221C2 |
METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS MULTIPLE DRUG-RESISTANCE OF TUBERCULOSIS MYCOBACTERIA | 2018 |
|
RU2687743C1 |
METHOD FOR TREATING HUMAN TUBERCULOSIS | 2002 |
|
RU2238091C2 |
METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2015 |
|
RU2587332C1 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS | 2002 |
|
RU2228197C1 |
METHOD FOR TREATMENT OF DESTRUCTIVE AND PROGRESSING LUNG TUBERCULOSIS FORMS CAUSED BY DRUG-RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS | 2000 |
|
RU2215538C2 |
SALT OF BIS(OXYMETHYL)PHOSPHINIC ACID WITH ISONICOTINIC ACID HYSRAZIDE (TUBOPHEN) HAVING ANTITUBERCULOSIS ACTION AND METHOD FOR PRODUCTION THEREOF | 2005 |
|
RU2281939C1 |
Authors
Dates
2022-09-05—Published
2021-08-04—Filed